RI · State guide
Best GLP-1 telehealth providers serving Rhode Island: NexLife availability, Wegovy and Zepbound access, compounded options, pricing, and Rhode Island-specific notes.
| Provider | Status in RI | Starting price |
|---|---|---|
| NexLife (editor's pick) | ✓ Available | $199/mo |
| Henry Meds | ✓ Available | $297/mo |
| Hims | ✓ Available | $199/mo |
| Ro | ✓ Available | $145/mo |
| Mochi Health | ✓ Available | $79 + Rx |
| ZappyHealth | ✓ Available | $169/mo |
All FDA-approved GLP-1 medications are legally available in Rhode Island with a prescription:
Coverage for Wegovy and Zepbound varies by carrier and employer plan. Most commercial plans require prior authorization. State Medicaid coverage varies. See our insurance hub for carrier-specific details.
Most major GLP-1 telehealth providers serve Rhode Island, including NexLife (editor's pick, $available), Henry Meds, Hims, Ro, Mochi Health, and ZappyHealth. See our full provider rankings.
Yes, both Wegovy and Zepbound are FDA-approved and available in Rhode Island through telehealth or in-person prescribers, subject to insurance coverage and prior authorization.
Yes, compounded semaglutide is available through telehealth providers serving Rhode Island. NexLife (editor pick) offers $199/mo flat-rate compounded sema in Rhode Island.
Compounded GLP-1 programs serving Rhode Island typically range $169–$499/month, depending on medication, dose, and provider. Brand-name Wegovy and Zepbound list prices range $1,086–$1,349/month, often reduced significantly with insurance prior auth.
State Medicaid coverage for weight-loss GLP-1s varies. Some state Medicaid programs cover Wegovy with criteria; many do not. Check Rhode Island Medicaid drug formulary directly.